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Isolated rat hepatocytes were incubated in the absence or presence of glucagon and the activity of fructose- 
1,6_bisphosphatase was measured in cell extracts. After glucagon treatment he Vmax was increased (20-50s) 
whereas the K,,, remained unchanged. The stimulation was complete at 5 min after addition of glucagon. The 
glucagon concentration needed for maximal stimulation was 10m9M. After gel filtration the fructose-1,6- 
bisphosphatase activity in extracts of glucagon-treated cells was lowered to the control level. The effect of 
glucagon could not be completely mimicked by dibutyryl CAMP. The data indicate that in addition to the 
possible regulatory role of enzyme phosphorylation, a positive effector is involved in the stimulation of 
fructose-1,6_bisphosphatase ctivity by glucagon. 
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1. INTRODUCTION 
Fructose-l ,6-bisphosphatase (EC 3.1.3.11; 
FBPase) is part of the regulatory important fruc- 
tose 1,6-bisphosphate/fructose 6-phosphate sub- 
strate cycle, and is thought to be regulatory for 
the gluconeogenic/glycolytic pathway [l]. Rat liver 
FBPase can be phosphorylated in vitro by CAMP- 
dependent protein kinase [2,3] and in hepatocytes 
its phosphorylation is increased by glucagon [4]. 
FBPases from mouse, rabbit and ox liver as well as 
from pig kidney cannot be phosphorylated [3,5], 
since they lack a C-terminal extension, containing 
the phosphorylation site [6]. The effect of 
phosphorylation on the kinetic properties of the 
enzyme is under dispute. An increase in Max [2], 
a decrease in Km [7], both an increase in I’,,,ax and 
a decrease in Km [8] or no change in Vmax and K,,, 
[2,6] have been reported. Phosphorylated FBPase 
has also been reported to be less sensitive to inhibi- 
tion by fructose 2,6-bisphosphate than the un- 
phosphorylated enzyme [9,27]. Phosphorylation 
of FBPase is not generally accepted as playing an 
important role in the regulation of gluconeogenesis 
and glycolysis [lo]. 
Allosteric regulation of FBPase can be per- 
formed by several metabolites. FBPase is inhibited 
by AMP [ll] and fructose 2,6-bisphosphate 
[12,13]. Since the fructose 2,6-bisphosphate level 
in hepatocytes is lowered after glucagon treatment 
[ 14,151, fructose 2,dbisphosphate has been put 
forward as the main factor controlling the activity 
of FBPase in vivo [lo] through a relief of enzyme 
inhibition. However, Corredor et al. [la] found 
that micromolar concentrations of fructose 
2,dbisphosphate can also stimulate FBPase 
activity. 
Administration of glucagon in vivo leads to in- 
creased activity of rat [17,18] and mouse [19] liver 
FBPase. Since mouse liver FBPase cannot be 
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phosphorylated [3,6] it is unlikely that 
phosphorylation plays a decisive role in determin- 
ing the activity of FBPase. 
Here, we show that treatment of hepatocytes 
with glucagon leads to a rapid increase in vmaX of 
FBPase. This increase is not due to phosphoryla- 
tion of the enzyme or to a change in fructose 
2,6-bisphosphate concentration, but is caused by a 
low-M, activator. 
2. MATERIALS AND METHODS 
Male Wistar rats (250 g) were anesthetized with 
18 mg Nembutal given intraperitoneally. Paren- 
chymal liver cells were isolated by perfusion with 
collagenase by the method of Seglen [20]. 2% 
albumin was added to the collagenase buffer and 
washing buffer. Cells were incubated in Krebs- 
Ringer with a protein concentration of 10 m&ml. 
The cells were kept in suspension by shaking in a 
water bath at 37°C and gassed with 95% 02, 5% 
COz. Viability of the cells was usually over 90% as 
judged by phase-contrast microscopy. Incubations 
were stopped by cooling in ice and after addition 
of 1 mM 2-mercaptoethanol samples were im- 
mediately homogenized. Homogenates were cen- 
trifuged for 10 min at 10000 x g. In the superna- 
tant, FBPase activity was assayed immediately 
after centrifugation and an Aminco DW2 double- 
beam spectrophotometer was used to monitor the 
assay at 3401400 nm. The assay mixture consisted 
of 10 mM potassium phosphate buffer (pH 7.5), 
25 mM 2-mercaptoethanol, 1 mg/ml albumin, 
2.5 mM MgS04, 0.4 mM NADP, 7 units 
glucose-6-phosphate dehydrogenase and 3.5 units 
phosphohexose isomerase (both enzymes were 
desalted on Sephadex G-25); final volume 2.3 ml. 
The mixture was preincubated with 2OOgl sample 
for 3 min at 30°C and the reaction initiated by the 
addition of 100 ~1 fructose 1,6-bisphosphate solu- 
tion. In the samples some 6-phosphogluconate 
dehydrogenase activity was present, but it was 
verified that under the present conditions it did not 
interfere with our measurements. The FDPase ac- 
tivity was determined between 1 and 3 min after 
starting the reaction, when V was nearly constant. 
Where indicated, aliquots of the supernatant frac- 
tion were desalted on Sephadex G-25 medium 
(equilibrated with HzO) by the method of Penev- 
sky [21]. The low-M, fraction was obtained by elu- 
tion and subsequent lyophilisation. Protein con- 
centrations were determined by the method of 
Lowry et al. [22]. L-type pyruvate kinase activity 
was determined as in [23]. Collagenase type I, 
bovine serum albumin fraction V, fructose 
1,6-bisphosphate and fructose 2,6-bisphosphate 
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Fig.1. Effect of glucagon on the FBPase activity. FBPase activity was measured in supernatants of control (e) and 
glucagon (lo-’ M, 10 min) treated ceIIs (m), before (A) and after (B) gel filtration. Inset: double-reciprocal plot of 
substrate curves of control and glucagon stimulated FBPase. Results shown are from a typical experiment (n = 7). 
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3. RESULTS AND DISCUSSION 
Substrate curves of FBPase from control and 
glucagon-stimulated parenchymal cells are given in 
fig.lA. After glucagon treatment the activity of 
FBPase is increased. The double-reciprocal plot in- 
dicates that the Vmax is increased by glucagon treat- 
ment whereas the K,,, (40 PM) remains unchanged. 
Routinely we found 20-40% stimulation of 
FBPase upon glucagon addition, although occa- 
sionally up to 70% stimulation was observed. To 
determine whether the increase in activity is caused 
by covalent modification or by the presence of an 
effector, the FBPase activity was determined in 
gel-filtered samples (fig. 1B). Upon gel filtration 
the activity of control samples was unchanged, 
while the activity in the glucagon-treated samples 
was lowered to the control level. This indicates that 
the increase in FBPase activity after glucagon 
treatment is not caused by phosphorylation but 
probably mediated by an effector. 
In our experiments however, an increased 
phosphorylation state of FBPase was indicated by 
the finding that in gel-filtered glucagon-treated 
samples FBPase was less sensitive to fructose 
2,6-bisphosphate inhibition than control FBPase, 
similar to the findings in 191. Since the activation 
of FBPase by glucagon can be abolished by gel 
filtration, a low-M, activator is suspected as being 
responsible for the observed difference. Readdi- 
tion of the low-M, fraction from glucagon-treated 
samples indeed leads to an increase in FBPase ac- 
tivity (table 1). The nature of this activator is 
however unclear. Activation of FBPase cannot be 
explained by decreased inhibition by fructose 
2,6-bisphosphate since gel filtration would then 
lead to increased FBPase activity of the control 
samples. Although we found, as did Corredor et 
al. [16], that 1 FM fructose 2,dbisphosphate could 
stimulate FBPase after gel filtration, fructose 
2,6-bisphosphate could not be responsible for ac- 
tivating FBPase after glucagon treatment because 
the concentrations of fructose 2,6-bisphosphate in 
the assay can be calculated to be about 2 nM for 
glucagon-treated and 20 nM for control samples, 
which are too low to stimulate FBPase. Calcula- 
tions were based on data from [24]. Moreover, in 
the presence of fructose 2,6-bisphosphate at in- 
hibiting concentrations, added low-M, fraction 
stimulates the FBPase activity, indicating that the 
activator is not fructose 2,dbisphosphate. To 
characterize further the kinetics of the stimulation 
of FBPase activity by glucagon we studied the dose 
and time dependency of the effect. Fig.2 shows 
that the effect is almost complete at 5 min after ad- 
dition of glucagon. Fig.3 indicates that 10s9 M 
glucagon is needed for maximal activation of 
FBPase activity, while half-maximal activation oc- 
curs at about lo-” M, which is well within the 
range of the glucagon dose needed for other 
gluconeogenic effects [lo]. 
Since the glucagon effect on gluconeogenesis can 
be mimicked by dibutyryl CAMP [lo], we com- 
pared the effect of dibutyryl CAMP with that of 
glucagon. Although dibutyryl CAMP was equally 
active as glucagon in inactivating L-type pyruvate 
kinase 1251, we observed only a marginal effect of 
dibutyryl CAMP on FBPase (table 2). This implies 
Table 1 
Effect of low-M, fraction on the activity of FBPase 
Cells incubated without glucagon Cells incubated with glucagon 
FBPase (pmol/min % stimu- FBPase (pmol/min Vo stimu- 
per mg protein) lation per mg protein) lation 
Control 553 f 51 - 519 f 31 
20 pl activator 623 f 33 13 589 f 39 14 
40 /rl activator 666 f ga 21 671 f 15a 29 
a Significant difference from control (P < 0.05, Student’s t-test, tested for equal variances) 
Low-M, fraction (‘activator’) was isolated and concentrated from a glucagon-stimulated sample. Different amounts (20, 
40~1) were added to assays of untreated and glucagon-treated gel-filtered samples. Values are given k SD (n = 3) 
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Fig.2. Time dependency of the FBPase activation by 
glucagon. FBPase activity was measured at 100~M 
fructose 1,6-bisphosphate, in supernatants of cell 
stimulated with glucagon (10m7 M) for different periods 
of time. Values are given f SE (n = 4). 
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Fig.3. Dose dependency of the FBPase activation by 
glucagon. FBPase activity was measured at 1OOpM 
fructose 1,6-bisphosphate in supernatants of cells 
stimulated with different doses of glucagon for 10 min. 
Values are given + SE (n = 5). 
that besides CAMP other second messengers might 
be involved, perhaps Ca2+, which is known to in- 
crease after glucagon treatment [26]. The dif- 
ference in the effects of glucagon and dibutyryl 
CAMP is a further indication against the involve- 
ment of CAMP-dependent phosphorylation or 
Table 2 
Influence of glucagon and dibutyryl CAMP on the fructose-1,6_bisphosphatase nd L-type pyruvate 
kinase activity 
FBPase (pmol/min % stimu- Pyruvate kinase % inhi- 
per mg protein) lation (v, VIII,,) bition 
Control 545 f 7 - 0.66 f 0.10 - 
Glucagon 675 + 6a 24 0.34 * O.Oga 51 
Dibutyryl CAMP 581 f 27 7 0.33 & 0.07” 50 
a Significant difference from control (P < 0.01, Student’s f-test tested for equal variances) 
FBPase and pyruvate kinase activity were measured in supernatants of cells stimulated with 
glucagon (lo-’ M) or dibutyryl CAMP (10e4 M) for 10 min. FBPase activity was measured at 
100 pM fructose 1 ,dbisphosphate. Pyruvate kinase was measured at 2 mM phosphoenolpyruvate 
in the absence (v) and presence (V,,,,,) of 50 PM fructose 1 ,dbisphosphate. Values are given rt: SD 
(n = 4) 
fructose 2,6-bisphosphate in the activation of 
FBPase in rat hepatocytes. Our data indicate that 
a low-M, activator is involved in the activation of 
FBPase by glucagon in rat hepatocytes. 
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